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Phosphatidylinositol 3-kinase regulates Raf1 through Pak
phosphorylation of serine 338 
A. Chaudhary*, W.G. King*, M.D. Mattaliano*†, J.A. Frost‡, B. Diaz§, 
D.K. Morrison#, M.H. Cobb‡, M.S. Marshall§¶ and J.S. Brugge*
We have previously shown that inhibition of
phosphatidylinositol (PI) 3-kinase severely attenuates the
activation of extracellular signal-regulated kinase (Erk)
following engagement of integrin/fibronectin receptors
and that Raf is the critical target of PI 3-kinase
regulation [1]. To investigate how PI 3-kinase regulates
Raf, we examined sites on Raf1 required for regulation
by PI 3-kinase and explored the mechanisms involved
in this regulation. Serine 338 (Ser338), which was
critical for fibronectin stimulation of Raf1, was
phosphorylated in a PI 3-kinase-dependent manner
following engagement of fibronectin receptors. In
addition, fibronectin activation of a Raf1 mutant
containing a phospho-mimic mutation (S338D) was
independent of PI 3-kinase. Furthermore,
integrin-induced activation of the serine/threonine
kinase Pak-1, which has been shown to phosphorylate
Raf1 Ser338, was also dependent on PI 3-kinase activity
and expression of a kinase-inactive Pak-1 mutant
blocked phosphorylation of Raf1 Ser338. These results
indicate that PI 3-kinase regulates phosphorylation of
Raf1 Ser338 through the serine/threonine kinase Pak.
Thus, phosphorylation of Raf1 Ser338 through
PI 3-kinase and Pak provides a co-stimulatory signal
which together with Ras leads to strong activation of
Raf1 kinase activity by integrins.
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Results and discussion
To identify residues of Raf1 involved in its integrin-induced
activation and to establish whether any of these sites are
regulated by PI 3-kinase, we first examined the ability of
fibronectin to activate variants of Raf1 containing alterations
in known phosphorylation sites (Figure 1a). Wild-type and
mutant variants of Raf were transiently expressed in COS7
cells and Raf1 activity was examined in immunoprecipitates
from cells held in suspension or attached to fibronectin for
15 minutes. The dependence of this activation on PI
3-kinase was determined by its sensitivity to wortmannin, a
pharmacological inhibitor of PI 3-kinase. 
As previously reported, wild-type Raf1 was activated by
attachment of cells to fibronectin and this activation was
inhibited by 50 nM wortmannin (Figure 1b,c) [1]. Mutation
of Ser621 to alanine (Figure 1b) prevented activation of Raf
following attachment to fibronectin. Mutation of the
tandem serines at positions 338 and 339 also blocked
fibronectin-induced activation (Figure 1b). The residual
activity detected after fibronectin stimulation was insensi-
tive to wortmannin. Mutation of Ser339 alone (S339A) had
no detectable effect on activation by fibronectin nor its sen-
sitivity to wortmannin inhibition (Figure 1c). Mutation of
Ser338 to alanine (S338A), however, prevented activation by
fibronectin (Figure 1c). These results indicate that Ser338 is
required for activation of Raf1 by fibronectin receptors.
Others have shown that loss of the Ser338 phosphorylation
site also blocks Raf1 activation by activated oncogenic
V12Ras, u -Src, EGF, PDGF and phorbol esters [2,3].
The S259A, T268A/T269A, S497A and S499A mutants of
Raf1 retained their ability to be activated by fibronectin
and, in each case, this activation was sensitive to wortman-
nin (see Supplementary material). Thus, the Thr268
autophosphorylation site, the Ser259 site of 14-3-3 binding
and Akt phosphorylation [4], Ser497 and Ser499, putative
sites of phosphorylation by PKC and ceramide-activated
kinase (reviewed in [5]), are not required for integrin acti-
vation of Raf1. The Y340A/Y341A double mutant also
showed no defect in its activation by fibronectin (see Sup-
plementary material). A second Raf1 variant in which
these two tyrosine residues were replaced by phenylala-
nines (Y340F/Y341F) showed a weaker activation upon
fibronectin attachment, yet this activation was inhibited
by wortmannin (see Supplementary material). These
results suggest that phosphorylation of Tyr340 and Tyr341
does not play a significant role in integrin stimulation of
Raf1. We were unable to detect an inducible tyrosine
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phosphorylation of Raf1 after fibronectin-dependent
adhesion of COS7 cells (data not shown). Although this
could reflect unstable phosphorylation at these sites, the
evidence that both the Y340A/Y341A and Y340F/Y341F
mutants retained the ability to be inducibly activated
upon adhesion to fibronectin and that this activation was
sensitive to wortmannin treatment suggests that these
sites do not play a significant role in PI 3-kinase-regulation
of integrin-mediated Raf1 activation. 
In summary, mutation of two phosphorylation sites,
Ser621 and Ser338, prevented activation of Raf1 upon
attachment of cells to fibronectin. We chose to focus on
Ser338 as a critical site in integrin stimulation and as a
potential target of PI 3-kinase regulation because the Raf1
S621A mutant shows no activity in the basal state and
Ser621 is phosphorylated constitutively [6]. 
PI 3-kinase is required for integrin-stimulated
phosphorylation of Raf1 Ser338 
To investigate whether Raf1 Ser338 is phosphorylated
after integrin stimulation and whether this phosphoryla-
tion is dependent on PI 3-kinase, we used a phospho-spe-
cific antiserum that recognizes phosphorylated Ser338 [2].
Upon adhesion of cells to fibronectin, Raf1 was inducibly
phosphorylated on Ser338 and this phosphorylation was
inhibited by 50 nM wortmannin (Figure 2a). These data
indicate that fibronectin receptors stimulate a PI 3-kinase-
dependent phosphorylation of Raf1 Ser338 in COS7 cells.
A dominant-inhibitory Pak-1 mutant blocks phosphorylation
of Raf1 Ser338
Protein kinases of the Pak family have recently been impli-
cated in the regulation of Raf through Ser338 phosphoryla-
tion. Pak-3 phosphorylates Raf1 Ser338 in vitro [2,3] and
overexpression of constitutively active Pak-3 leads to phos-
phorylation of Ser338 in vivo. In addition, overexpresssion
of a kinase-inactive Pak-3 mutant significantly reduces the
basal activity of the membrane-targeted Raf-CX and the
V12Ras-inducible activation of wild-type Raf1 [2]. These
data and the evidence that Pak-1 is activated by integrin
receptor engagement [7] led us to investigate whether
fibronectin-induced Ser338 phosphorylation is affected by
a dominant-inhibitory Pak-1 mutant. We coexpressed a
kinase-inactive Pak-1 mutant (Pak-1 K298A) with Raf1 in
COS7 cells and examined Ser338 phosphorylation
(Figure 2a). The phosphorylation of Ser338 was indeed
inhibited upon coexpression of this Pak-1 variant. Coex-
pression of V12Ras with Raf1 was used as a positive control
(Figure 2a) because this is known to induce a high level of
Ser338 phosphorylation [2]. These data suggest that Pak
family kinases are involved in fibronectin stimulation of
Ser338 phosphorylation. 
Activation of the Raf1 S338D/S339E mutant is independent
of PI 3-kinase
To further investigate the role of Ser338 in PI 3-kinase reg-
ulation of Raf, we examined the response of the Raf1
S338D/S339E double mutant to PI 3-kinase inhibition.
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Figure 1
(a) Selected phosphorylation sites on Raf1.
Amino acids are indicated by the single letter
code and residue number. Most sites shown in
this figure are reviewed in [5]. Exceptions
include the phosphorylation of S259 by Akt [4],
phosphorylation of S621 by AMP-activated
protein kinase (AMP-PK) [18] and
phosphorylation of S338 by Pak-3 [2]. CR1
and CR2 refer to cysteine-rich regions 1 and 2.
(b,c) Activation of Raf1 mutants upon
attachment to fibronectin and its inhibition by
wortmannin. COS7 cells expressing wild-type
(WT) or mutant Raf1 proteins were serum-
starved, detached from the tissue culture dish,
pretreated in the presence (+) or absence (–)
of 50 nM wortmannin for 15 min, and then held
in suspension (S) or incubated on fibronectin
dishes (F) for 15 min. In vitro kinase assays
were performed using GST–KD-MEK1 as
substrate after immunoprecipitating (IP) Raf1
proteins with either anti-FLAG M2 or anti-Raf1
(C12) primary antibodies, as indicated. Upper
panels show the Raf1 kinase assays, and the
corresponding Raf1 protein immunoblots (IB),
are shown in the lower panels. The wild-type
Raf1 control for each of the four
representative experiments is shown in
adjacent lanes to facilitate comparison of
relative inhibitions of activity. The fibronectin-
inducibility and wortmannin-dependence for
each of these variants was examined in at
least two experiments.
bb10i57.qxd  10/5/00  9:15 am  Page 552
This mutant is a chemical mimic of Raf1 doubly phos-
phorylated on serine residues 338 and 339. Although this
mutant showed a 4–5-fold lower basal activity than wild-
type Raf1, this activity was still stimulated significantly
(2–3-fold) following attachment of cells to fibronectin. It is
noteworthy that we consistently observed no inhibition of
this fibronectin-induced activity by wortmannin (Figure 2b
and see Supplementary material), nor upon coexpression
with a dominant-negative mutant of the p85 subunit of
PI 3-kinase (D p85 PI 3-kinase; Figure 2c), suggesting that
mimicking the phosphorylation of Raf1 Ser338 and Ser339
circumvents the dependence on PI 3-kinase. As observed
previously [8], the S338D/S339E mutant did not show ele-
vated basal activity, most likely because Ras interaction is
required to relieve negative regulatory interactions involv-
ing the amino-terminal half of Raf1. The lower stimulated
kinase activity of this mutant compared with wild type
might reflect the inability of the S338D/S339E substitution
to exactly mimic phosphorylation of Ser338 and Ser339.
Integrin-induced activation of Pak-1 is dependent on
PI 3-kinase
Because our results (Figure 2a) and a previous report [2]
have implicated Pak in Ser338 phosphorylation and the
phosphorylation of this site was blocked by inhibition of
PI 3-kinase activity, we examined whether integrin activa-
tion of Pak-1 was sensitive to PI 3-kinase inhibition.
Fibronectin was previously shown to induce a strong acti-
vation of Pak-1 in NIH3T3 fibroblasts [7]; however, the
PI 3-kinase-dependence of this activation was not exam-
ined. Upon attachment of COS7 cells to fibronectin, Pak-1
was activated 12-fold compared with cells held in suspen-
sion (Figure 3a and see Supplementary material). Approxi-
mately 80% of this activation was sensitive to inhibition by
50 nM wortmannin. This result suggests that PI 3-kinase
is required for Pak stimulation by fibronectin receptors. 
Expression of kinase-inactive Pak-1 reduces Raf activation 
To further explore the role of Pak in Raf regulation, we
examined the effects of Pak-1 on the kinase activity of
Raf1. We have shown that kinase-inactive Pak-1 inhibits
Raf1 Ser338 phosphorylation following fibronectin stimula-
tion; however, it was of interest to directly examine the
effect of this Pak-1 mutant on fibronectin stimulation of
Raf1 kinase activity. Pak-1 K298A was coexpressed with
Raf1 in COS7 cells and Raf1 kinase activity was measured
in vitro. Coexpression of Pak-1 K298A caused a 50% inhibi-
tion in the activation of Raf1 by fibronectin (Figure 3b and
see Supplementary material). The residual Raf1 activation
was consistently insensitive to inhibition by 50 nM wort-
mannin. This wortmannin-insensitivity and the evidence
that kinase-inactive Pak-1 was less effective in blocking
Raf1 activation than wortmannin raise the possibility that
kinase-inactive Pak-1 might stimulate alternative mecha-
nisms, independent of PI 3-kinase and Raf1 Ser338, that
lead to Raf1 activation. Kinase-inactive mutants of Pak-1
induce very dramatic cytoskeletal alterations [9], indicating
that regions outside the catalytic domain (for example, the
proline-rich regions which bind to PIX and Nck) can acti-
vate intracellular signaling pathways.
This report provides new insights into one mechanism by
which PI 3-kinase can regulate activation of the Erk
pathway through Raf1. These studies raise the question of
how integrins can regulate Pak through a PI 3-kinase-
dependent mechanism and suggest the model shown in
the Supplementary material. Tracing this proposed
pathway backwards from Pak, the Pak family kinases are
known to be regulated by binding Cdc42 or Rac [9].
Because PI 3-kinase regulates guanine nucleotide
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Figure 2
(a) Inducibility of Raf1 Ser338 phosphorylation upon attachment to
fibronectin and its inhibition by wortmannin and by coexpression of
kinase-inactive Pak-1. COS7 cells expressing FLAG-tagged Raf1
alone, or FLAG-tagged Raf1 in combination with Myc-tagged Pak-1
K298A or V12Ras were serum-starved and left attached (Ad),
detached and held in suspension (S), or detached and plated on
fibronectin-coated dishes (F). Cells used in lanes 4 and 8 were treated
with 50 nM wortmannin (+). Phosphorylation of Ser338 was detected
using an antiserum specific for phospho-Ser338. The lower panel
shows the same immunoblot reprobed with anti-Raf antiserum after
stripping the PVDF membrane. This figure is representative of data
obtained in two separate experiments. (b,c) Activation of Raf1
S338D/S339E on fibronectin is insensitive to inhibition by wortmannin
and D p85 PI 3-kinase. In vitro kinase assays were performed using
Raf1 immunoprecipitated from cells expressing either WT Raf1 or
S338D/S339E Raf1 alone or either of these together with D p85
PI 3-kinase, as indicated. Upper panels show Raf1 kinase assays using
GST–KD-MEK1 as substrate. Lower panels show the corresponding
Raf1 protein immunoblot. Cells were treated as described in (a).
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exchange factors (GEFs) for Cdc42 and Rac (for example,
Vav [10], SOS [11], PIX/Cool [12]) and is required for Rac-
mediated events [13], PI 3-kinase regulation of Pak could
be mediated through the activation of Rac or Cdc42 GEFs.
Pix/Cool is one such possible exchange factor because it
binds directly to Pak and is regulated by PI 3-kinase [12,14].
PI 3-kinase activation by integrins and growth factors
depends on interaction of the p110 catalytic subunit of PI
3-kinase with Ras [15]. Therefore, fibronectin-induced
Ras–GTP could activate PI 3-kinase, which could then acti-
vate a Cdc42 or Rac exchange factor, leading to GTP
loading onto Cdc42 or Rac, and thus activation of Pak. The
ability of dominant-inhibitory Cdc42 to inhibit Erk activa-
tion in Rat1 cells attached to fibronectin [16] is consistent
with this possibility. A recent study demonstrating regula-
tion of Raf1 catalytic activity by oncogenic Ras through the
stimulation of a pathway involving PI 3-kinase, Cdc42 or
Rac, and Pak further supports this proposal [17].
Supplementary material
Additional methodological details, data on fibronectin-induced activa-
tion of Raf1 mutants, quantitation of Raf1 activation data and a model
for PI 3-kinase regulation of Raf1 are available at http://current-
biology.com/supmat/supmatin.htm. 
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Figure 3
(a) Activation of Pak-1 on attachment to fibronectin and sensitivity to
wortmannin inhibition. An in-gel assay for Pak kinase activity was
performed as described previously [7]. Briefly, COS7 cells transfected
with Myc–Pak-1 were serum-starved and then left attached to the plate
(Ad), held in suspension (S) or plated on fibronectin-coated dishes for
15 min (F) in the presence or absence of wortmannin. Proteins were
immunoprecipitated (IP), separated by 12.5% SDS–PAGE, and kinase
activities assayed in situ. The upper panel shows the kinase assay and
the lower panel shows the Pak-1 protein immunoblot (IB). The results are
representative of two separate experiments. (b) Activation of Raf1 on
fibronectin and its wortmannin sensitivity upon coexpression of kinase-
inactive Pak-1. COS7 cells expressing Raf1 alone or in combination with
Pak-1 K298A were serum-starved and then left attached to the plate
(Ad), held in suspension (S) or plated on fibronectin-coated dishes for
15 min (F) in the presence or absence of wortmannin. In vitro Raf kinase
assays were performed as described in Figure 1b. The upper panel
shows the kinase assay, the middle panel shows the corresponding Raf1
immunoblot, and the lower panel shows total cell lysates probed for
Pak-1. The data are representative of three separate experiments. 
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